Sponsor Pipeline

Marubeni Pharmaceuticals (Suzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07697885
Lefamulin Post-Market Surveillance Study		 Recruitment opened
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07697885 Lefamulin Post-Market Surveillance Study Community-Acquired Pneumonia (CAP) Recruiting
Get alerts when Marubeni Pharmaceuticals (Suzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free